Stockreport

Rallybio Announces Promising RLYB212 and RLYB332 Preclinical Data at the 66th American Society of Hematology Annual Meeting [Yahoo! Finance]

Rallybio Corporation  (RLYB) 
PDF advances into transformative therapies for patients with devastating rare diseases, today announced the presentation of two posters highlighting promising preclinical da [Read more]